Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats

Psychopharmacology

Volumn 158, Issue 4, 2001, Pages 374-381

  Zorrilla, E P ^a   Valdez, G R ^a   Weiss, F ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Abstinence; Amygdala; Cocaine; Corticosterone; Corticotropin releasing factor; Ethanol; Withdrawal

Indexed keywords

ALCOHOL; COCAINE; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR;

ALCOHOL WITHDRAWAL; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DRUG DEPENDENCE; DRUG SELF ADMINISTRATION; DRUG WITHDRAWAL; FRONTAL CORTEX; HIPPOCAMPUS; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOREACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; BRAIN; COCAINE; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; ETHANOL; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PITUITARY-ADRENAL SYSTEM; RADIOIMMUNOASSAY; RATS; RATS, WISTAR; SELF ADMINISTRATION;

EID: 0035207886     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130100773     Document Type: Article

References (72)

1. Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and diazepam-binding inhibitor (DBI) during alcohol withdrawal and abstinence
2. Cocaine- but not food-seeking behavior is reinstated by stress after extinction
3. Studies on duration of a late recovery period after chronic abuse of ethanol. A cross-sectional study of biochemical and psychiatric indicators
4. Regional binding to corticotropin releasing factor receptors in brain of rats exposed to chronic cocaine and cocaine withdrawal
5. Circadian variation in basal plasma corticosterone and adrenocorticotropin in the rat: Sexual dimorphism and changes across the estrous cycle
6. Adrenocorticotropin and cortisol responses to ovine corticotropin-releasing factor in alcohol dependence disorder. Preliminary report
7. Corticotropin-releasing factor antagonist attenuates the "anxiogenic-like" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats
8. Persistence of a "subacute withdrawal syndrome" following chronic ethanol intake
9. The neuropsychiatry of cocaine abuse
10. Chronic cocaine administration sensitizes behavioral but not neuroendocrine responses
11. ICV administration of CRF blocker (CRF9-41 delta helical) reduces morphine withdrawal in rats
12. Intravenous drug self-administration techniques in animals
13. Acute and protracted cocaine abstinence in an outpatient population: A prospective study of mood, sleep and withdrawal symptoms
14. An assessment of hypothalamo-pituitary-adrenal axis functioning in non-depressed, early abstinent alcoholics
15. Ethanol exposure decreases pituitary corticotropin-releasing factor binding, adenylate cyclase activity, proopiomelanocortin biosynthesis, and plasma beta-endorphin levels in the rat
16. Symptomatology in alcoholics at various stages of abstinence
17. Long-term recovery in alcoholics
18. Corticotropin-releasing factor receptors: Physiology, pharmacology, biochemistry and role in central nervous system and immune disorders
19. Plasma concentrations of beta-endorphin, adrenocorticotropic hormone, and cortisol in drinking and abstinent chronic alcoholics
20. Glucocorticoids and behavioral effects of psychostimulants II: Cocaine intravenous self-administration and reinstatement depend on glucocorticoid levels
21. Chronic ethanol exposure potentiates the locomotor-activating effects of corticotropin-releasing factor (CRF) in rats
22. Time-dependent alterations in corticotropin-releasing factor-like immunoreactivity in different brain regions after acute cocaine administration to rats
23. Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans
24. Overexcitement and disinhibition. Dynamic neurotransmitter interactions in alcohol withdrawal
25. Effect of naloxone administration upon responses of adrenal hormones to withdrawal from ethanol
26. Alcohol withdrawal symptoms and drinking behavior
27. 24-Hour pulsatile and circadian patterns of cortisol secretion in alcoholic men
28. Stress, corticotropin-releasing factor, and drug addiction
29. Neurobiology of addiction. Toward the development of new therapies
30. A role for corticotropin releasing factor and urocortin in behavioral responses to stressors
31. The role of corticotropin-releasing factor in behavioural responses to stress
32. Electroencephalographic sleep and mood during cocaine withdrawal
33. Brain corticotropin-releasing factor immunoreactivity and receptors in five inbred rat strains: Relationship to forced swimming behaviour
34. Reinstatement of alcohol-seeking by priming injections of alcohol and exposure to stress in rats
35. The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats
36. Prolonged exposure to intermittent alcohol vapors blunts hypothalamic responsiveness to immune and non-immune signals
37. Thyroid and adrenal dysfunction in abstinent alcoholic men: Locus of disturbance
38. Blunted stress cortisol response in abstinent alcoholic and polysubstance-abusing men
39. Time-dependent quantifiable withdrawal from ethanol in the rat: Effect of method of dependence induction
40. Measurement of extracellular neuropeptide in the brain: Microdialysis linked to solid-phase radioimmunoassays with sub-femtomole limits of detection
41. Beta-endorphin, adrenocorticotropic hormone and cortisol secretion in abstinent alcoholics
42. Postcocaine anhedonia. An animal model of cocaine withdrawal
43. Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation
44. The role of corticotropin-releasing factor in the anxiogenic effects of ethanol withdrawal
45. Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine
46. Glucocorticoids as a biological substrate of reward: Physiological and pathophysiological implications
47. The role of stress in drug self-administration
48. Corticosterone levels determine individual vulnerability to amphetamine self-administration
49. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis
50. Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal
51. Effects of ethanol on CRF release in vitro
52. In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats
53. Sensitization of cocaine-stimulated increase in extracellular levels of corticotropin-releasing factor from the rat amygdala after repeated administration as determined by intracranial microdialysis
54. Stimulatory effect of cocaine on ACTH secretion: Role of the hypothalamus
55. Cocaine stimulates adrenocorticotropin (ACTH) secretion through a corticotropin-releasing factor (CRF)-mediated mechanism
56. Effect of ethanol on the hypo-thalamic-pituitary-adrenal axis in the rat: Role of corticotropin-releasing factor (CRF)
57. Prolonged exposure to alcohol: Effect on CRF mRNA levels, and CRF- and stress-induced ACTH secretion in the rat
58. Cocaine self-administration alters the morphology of dendrites and dendritic spines in the nucleus accumbens and neocortex
59. Hyperventilation, anxiety, craving for alcohol: A subacute alcohol withdrawal syndrome
60. The cocaine-induced elevation of plasma corticosterone is mediated by endogenous corticotropin-releasing factor (CRF) in rats
61. Brain corticotropin-releasing factor mediates "anxiety-like" behavior induced by cocaine withdrawal in rats
62. Induction of corticotro-pin-releasing hormone gene expression by glucocorticoids: Implication for understanding the states of fear and anxiety and allostatic load
63. Effects of chronic ethanol exposure on oral self-administration of ethanol or saccharin by Wistar rats
64. Effects of chronic ethanol exposure on neurophysiological responses to corticotropin-releasing factor and neuropeptide Y
65. Pathways to relapse: The neurobiology of drug-and stress-induced relapse to drug-taking
66. Repeated and chronic morphine administration causes differential long-lasting changes in dopaminergic neurotransmission in rat striatum without changing its delta- and kappa-opioid receptor regulation
67. Cocaine-induced stimulation of the rat hypothalamic-pituitary-adrenal axis is progressively attenuated following hourly-interval regimens of the drug
68. Alterations in the hypothalamic-pituitary-adrenal axis in actively drinking alcoholics
69. Hypothalamic-pituitary function during alcohol exposure and withdrawal and cocaine exposure
70. Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during "binge"-pattern cocaine administration and chronic withdrawal